QMS Medical Allied Services Q2 Results 2026: PAT ₹2 Cr
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹53Cr
- Net profit
- ₹2Cr
- Margin
- 12.4%
Top 10 Healthcare Equipment & Supplies companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on QMS Medical Allied Services Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
For the quarter ended 30 September 2026, consolidated revenue from:. Quarterly figures (Q2 FY 2026-27 ended 30 Sep 2026) from presentation:.
From QMS Medical Allied Services Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did QMS Medical Allied Services' revenue grow in the September 2026 quarter?
- For the quarter ended 30 September 2026, consolidated revenue from:
- Sale of products: Rs. 2,787.79 lakhs (down from Rs. 3,375.26 lakhs in Q2 2025)
- Sale of services: Rs. 2,464.68 lakhs (up from Rs. 1,094.74 lakhs in Q2 2025)
- Total consolidated revenue: Rs. 5,252.47 lakhs (up from Rs. 4,470.00 lakhs in Q2 2025), a year-on-year increase of approximately 17.5%
- Standalone results for quarter ended 30 September 2026:
- Sale of products: Rs. 2,636.11 lakhs vs Rs. 3,375.26 lakhs in Q2 2025 (decline)
2 more points from QMS Medical Allied Services Ltd's call on revenue
Create a free account to keep reading this call
What happened to QMS Medical Allied Services' margins in Q2 FY27?
Quarterly figures (Q2 FY 2026-27 ended 30 Sep 2026) from presentation:
Locked: what QMS Medical Allied Services Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
What capex is QMS Medical Allied Services planning?
- On September 25, 2026, the Board approved acquisition of 100% equity shares of BeamOptics Scientific Private Limited, a Pune-based optics, diagnostics, and analytical instruments manufacturer.
- Consideration for acquisition determined by independent valuation; payment may be cash, share swap, or both.
- Acquisition pending fulfillment of transaction conditions and National Company Law Tribunal (NCLT) approval.
- Composite Scheme of Arrangement approved on September 25, 2026, for demerger of Healthcare Services Business into Saarathi Healthcare Private Limited, a wholly owned subsidiary, which will seek NSE listing.
2 more points from QMS Medical Allied Services Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is QMS Medical Allied Services raising money or cutting debt?
Borrowings as per Unaudited Consolidated Assets and Liabilities (Page 16) show:
Locked: what QMS Medical Allied Services Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
How big is QMS Medical Allied Services' order book?
See what QMS Medical Allied Services Ltd said on order book & pipeline — free account, 30 seconds.
QMS Medical Allied Services Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the table below.
QMS Medical Allied Services Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 53 |
| Operating profit (EBITDA) | 7 |
| Operating margin | 12.4% |
| Profit before tax | 3 |
| Net profit (PAT) | 2 |
| EPS (₹) | 1.26 |
Source: QMS Medical Allied Services Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹57 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Healthcare Equipment & Supplies
- Molbio Diagnosti Q2 FY27 results
- Poly Medicure Q2 FY27 results
- Sahajanand Medi Q2 FY27 results
- Fischer Medical Q2 FY27 results
- Tarsons Products Q2 FY27 results
- Laxmi Dental Q2 FY27 results
- Vasa Denticity Q2 FY27 results
- OSEL Devices Q2 FY27 results
All Q2 FY27 results | Healthcare Equipment & Supplies rankings
Continue your research
What QMS Medical's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Fischer Medical (Q2 FY27)
For the quarter ended September 30, 2026, the Standalone revenue from operations was ₹27.62 Lakhs compared to ₹742.69 Lakhs in Q2 FY 2025, showing a…
- Mohini Health (Q2 FY27)
Revenue from operations for the half year ended 30th Sept 2026 is ₹11,043.00 lakhs, compared to ₹7,353.87 lakhs for the half year ended 30th Sept 2025, showing…
- Aprameya Enginee (Q2 FY27)
216.21 lakhs, up 97% year-on-year (YoY). Key results statement takeaways from Aprameya Engineering Ltd's Q2 FY27 results statement — and how it ranks against se
- OSEL Devices (Q2 FY27)
31.8% increase ((19,363.37 . Key results statement takeaways from OSEL Devices Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
QMS Medical Allied Services Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were QMS Medical Allied Services Ltd Q2 FY27 results?
For the quarter ended 30 September 2026, consolidated revenue from:. Quarterly figures (Q2 FY 2026-27 ended 30 Sep 2026) from presentation:.
What is QMS Medical Allied Services Ltd share price analysis?
QMS Medical Allied Services Ltd currently shows a neutral. The stock trades at a P/E of 31.3 with a market cap of ₹336 Cr. Investors should review the full earnings analysis for detailed insights.
Is QMS Medical Allied Services Ltd planning capital expenditure?
On September 25, 2026, the Board approved acquisition of 100% equity shares of BeamOptics Scientific Private Limited, a Pune-based optics, diagnostics, and analytical instruments manufacturer.
Keep QMS Medical Allied Services Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
